Rajesh Vashistha
Overview
Explore the profile of Rajesh Vashistha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katake A, Kumar L, Singh B, Mishra N, Gurjar P, Vashistha R, et al.
Asian Pac J Cancer Prev
. 2024 Dec;
25(12):4381-4389.
PMID: 39733431
Aim: To study the dosimetric behavior of dose computational algorithms in inhomogeneous medium using CMS XiO and MONACO treatment planning system (TPS) for 4 megavoltage (MV), 6 MV and 15...
2.
Chhichholiya Y, Singh H, Vashistha R, Singh S, Munshi A
Crit Rev Oncol Hematol
. 2023 Dec;
194:104250.
PMID: 38143047
Cancer is a significant cause of death after cardiovascular disease. The genomic, epigenetic and environmental factors have been found to be the risk factor for the disease. The most important...
3.
Singh B, Singh G, Oinam A, Singh M, Katake A, Kumar V, et al.
J Cancer Res Ther
. 2023 Jul;
19(3):738-744.
PMID: 37470603
Purpose: The purpose of the study was to estimate the fitting parameters of the sigmoidal dose response (SDR) curve of radiation-induced acute dermatitis in breast cancer patients treated with intensity-modulated...
4.
Singh B, Singh G, Oinam A, Singh M, Kumar V, Vashistha R, et al.
J Cancer Res Ther
. 2023 Jul;
19(3):664-670.
PMID: 37470591
Purpose: To estimate the fitting parameters of the sigmoidal dose response (SDR) curve of radiation-induced acute proctitis in prostate cancer patients treated with intensity modulated radiation therapy (IMRT) for the...
5.
Mittal P, Chopra S, Kamrava M, Vashistha R, Konrad S, Senapati S, et al.
Brachytherapy
. 2023 May;
22(4):562-569.
PMID: 37193616
Introduction: Brachytherapy (BT) is integral in treatment of gynecological malignancies and is also an option for many other cancers. Data on training and proficiency levels of early career oncologists is...
6.
Singh B, Singh G, Oinam A, Kumar V, Vashistha R, Sidhu M, et al.
J Cancer Res Ther
. 2023 May;
19(Supplement):S0.
PMID: 37147948
Purpose: This study aimed to estimate the fitting parameters of sigmoidal dose-response (SDR) curve of radiation-induced acute rectal mucositis in pelvic cancer patients treated with Intensity Modulated Radiation Therapy (IMRT)...
7.
Singh B, Singh G, Oinam A, Kumar V, Vashistha R, Sidhu M, et al.
J Cancer Res Ther
. 2023 May;
19(Supplement):S0-S1715.
PMID: 37147947
Purpose/objective(s): This study aimed to estimate the fitting parameters of sigmoidal dose-response (SDR) curve of radiation-induced acute oral and pharyngeal mucositis in head-and-neck (H and N) cancer patients treated with...
8.
Talapatra K, Gupta M, Singh K, Giri G, Vashistha R
J Cancer Res Ther
. 2020 Jul;
16(3):638-640.
PMID: 32719281
Covid19 has become a major public health problem in India and the rest of the world. The dramatic rise in the incidence of COVID 19 cases has severely challenged our...
9.
Kaur R, Kumar V, Shafi G, Vashistha R, Kulharia M, Munshi A
Med Oncol
. 2019 Jun;
36(8):70.
PMID: 31203460
Alterations in BRCA2, PALB2, CHEK2, and p53 genes have been identified for their association with male breast cancer in various studies. The incidence of male breast cancer in India is...
10.
Singla H, Kaur R, Shafi G, Vashistha R, Banipal R, Kumar V, et al.
Mol Biol Rep
. 2018 Dec;
46(1):823-831.
PMID: 30535550
Human epidermal growth factor receptor 2 positive (HER2+) breast cancer (BC) is an aggressive BC subtype characterized by HER2 overexpression/amplification. Genomic alterations of HER2 and others have been reported to...